Acute lower respiratory tract infections in patients with rheumatoid arthritis

Journal of Rheumatology

Volumn 34, Issue 9, 2007, Pages 1832-1836

  Coyne, Peter ^a   Hamilton, Jennifer ^a   Heycock, Carol ^a   Saravanan, Vadivelu ^a   Coulson, Elizabeth ^a   Kelly, Clive A ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Infection; Methotrexate; Mortality; Pneumonia; Rheumatoid arthritis

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE; STEROID; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ACUTE DISEASE; AGED; AGING; ARTICLE; CONTROLLED STUDY; DRUG MONITORING; FEMALE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; LOW DRUG DOSE; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MEN'S HEALTH; MONOTHERAPY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

AGE FACTORS; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; PNEUMONIA; PREDNISOLONE; RISK FACTORS; SEX FACTORS;

EID: 35948943803     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Emery P, Suarez-Almazor M, Musculoskeletal disorders: rheumatoid arthritis. In: Young C, editor. Clinical evidence. London: BMJ Publishing Group; 2003:1454-76.
2. Mutru O, Laakso M, Isomaki H, Koota K. Ten-year mortality and causes of death in patients with rheumatoid arthritis. BMJ 1985;290:1797-9.
3. Albert LJ. Infection and rheumatoid arthritis: guilt by association? J Rheumatol 2000;27:564-6.
4. Doran M, Crowson CS, Pond GR, O'Fallon M, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum 2002;46:2287-93.
5. Doran M, Crowson CS, Pond GR, O'Fallon M, Gabriel SE. Predictors of infection in rheumatoid arthritis. Arthritis Rheum 2002;46:2294-300.
6. Vandenbroucke JP, Kaaks R, Valkenburg HA, et al. Frequency of infections among rheumatoid arthritis patients, before and after disease onset. Arthritis Rheum 1987;30:810-3.
7. Vandenbroucke JP, Hazevoet HM, Cats A. Survival and cause of death in rheumatoid arthritis: a 25-year prospective follow up. J Rheumatol 1984;11:158-61.
8. Capell HA, Murphy EA, Hunter JA. Rheumatoid arthritis: workload and outcome over 10 years. Q J Med 1991;79:461-76.
9. Prior P, Symmons DPM, Scott DL, Brown R, Hawkins CF. Cause of death in rheumatoid arthritis. Br J Rheumatol 1984;23:92-9.
10. Luqmani R, Hennell S, Estrach C, et al. British Society for Rheumatology and British Health Professionals in Rheumatology guidelines for the management of rheumatoid arthritis (the first two years). Rheumatology Oxford 2006;45:1167-9.
11. Maetzel A, Wong A, Strand V, Tugwell P, Wells G, Bombardier C. Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs. Rheumatology Oxford 2000;39:975-81.
12. Grove ML, Hassell AB, Hay EM, Shadforth M. Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice. Q J Med 2001;94:309-19.
13. Howes M, Tose J, White C, Kumar N, Heycock C, Kelly CA. Can baseline pulmonary function tests predict pulmonary toxicity in patients receiving methotrexate for rheumatoid arthritis? Intern Med 1999;7:51-4.
14. Lim AYN, Gaffney C, Scott DGL. Methotrexate induced pancytopaenia: serious and under-reported? Our experience of 25 cases in 5 years. Rheumatology Oxford 2005;44:1051-5.
15. Fraenkel L, Bogardus S, Concato J, Felson D. Unwillingness of rheumatoid arthritis patients to risk adverse effects. Rheumatology Oxford 2002;41:253-61.
16. Van der Veen MJ, van der Heide A, Kruize AA, Biljsma JW. Infection rate and use of antibiotics in patients with rheumatoid arthritis treated with methotrexate. Ann Rheum Dis 1994;53:224-8.
17. Bartlett JG, Dowell SF, Mandell LA, et al. Practice guidelines for the management of community acquired pneumonia in adults. Clin Infect Dis 2000;31:347-82.
18. Arnett FC, Edworthy, SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
19. Taylor WJ, Helliwell PS, Gladman DD, et al. A validation of current classification criteria for the diagnosis of psoriatic arthritis - preliminary results of the CASPAR study. Ann Rheum Dis 2005;64 Suppl 3:107.
20. Searles G, McKendry RJ. Methotrexate pneumonitis in rheumatoid arthritis: potential risk factors. Four case reports and a review of the literature. J Rheumatol 1987;14:1164-71.
21. Guidelines for management of community acquired pneumonia in adults. British Thoracic Society. Thorax 2000;56:827-34.
22. Wolfe W, Caplan L, Michaud K. Treatment for rheumatoid arthritis and the risk of hospitalisation for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs and anti-tumour necrosis factor therapy. Arthritis Rheum 2006;54:628-34.
23. Jinks M, Kelly CA. The pattern and significance of abnormal liver function tests in community-acquired pneumonia. Eur J Intern Med 2004;15:436-40.
24. Saravanan V, Kelly CA. Drug related pulmonary problems in patients with rheumatoid arthritis. Rheumatology Oxford 2006;45:787-90.
25. Peltomaa R, Paimela L, Kautianien H, Leirisalo-Repo M. Mortality in patients with rheumatoid arthritis treated actively from time of diagnosis. Ann Rheum Dis 2002;61:889-94.
26. Lindqvist E, Eberhardt K. Mortality in rheumatoid arthritis patients with disease in the 1980s. Ann Rheum Dis 1999;58:1-14.
27. Rajasekaran BA, Shovlin D, Lord P, Kelly CA. Interstitial lung disease in patients with rheumatoid arthritis: a comparison with cryptogenic rheumatoid arthritis. Rheumatology Oxford 2001;40:1022-5.
28. Rajasekaran BA, Shovlin D, Saravanan V, Lord P, Kelly CA. Interstitial lung disease in patients with rheumatoid arthritis; a comparison with cryptogenic fibrosing alveolitis over five years. J Rheumatol 2006;33:1250-4.
29. Kapetanovic MC, Saxrre T, Sjohotm A, Truedsson L, Jonsson G, Geborek P. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology Oxford 2006;45:106-11.